Embryonic hepatocyte transplantation for hepatic cirrhosis: Efficacy and mechanism of action

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

405

HTML

4766

Figures (1-9)

257

Tables (1-8)

264

Sum=5692

Jan 28, 2012 (publication date) through Dec 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jan 28, 2012; 18(4): 309-322
Published online Jan 28, 2012. doi: 10.3748/wjg.v18.i4.309

Table 8 Effects of embryonic hepatocyte transplantation in rats on different mRNA expression (mean ± SD, n = 9)

^bP < 0.01 vs the normal control group;

^dP < 0.01 vs the untreated cirrhotic group. STAP: Stellate activation-associated protein; SMA: Smooth muscle actin; ET: Endothelin.

Citation: Bin WT, Ma LM, Xu Q, Shi XL. Embryonic hepatocyte transplantation for hepatic cirrhosis: Efficacy and mechanism of action. World J Gastroenterol 2012; 18(4): 309-322
URL: https://www.wjgnet.com/1007-9327/full/v18/i4/309.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i4.309